Hillary Clinton Hillary Diane Rodham ClintonButtigieg stands in as Pence for Harris's debate practice Senate GOP sees early Supreme Court vote as political booster shot Poll: 51 percent of voters want to abolish the electoral college MORE is launching ads that take credit for a pharmaceutical company's decision last week to roll back its 4,000 percent price increase of a life-saving drug.

ADVERTISEMENT

Clinton’s campaign has purchased ads in Iowa and New Hampshire to draw attention to her attack on Turing Pharmaceuticals, a company that drew national scorn for dramatically raising the pricetag of a decares-old drug that’s commonly used to treat AIDS patients.

The price increase was rolled back one day after Clinton accused the company’s CEO of “price gouging” on Twitter.

Clinton’s campaign said the back-and-forth demonstrated that the candidate “is already getting results in her fight to curb prescription drug costs,” according to a statement from her campaign announcing the ad Monday.

The story of the company’s massive price increase, driven by a former Wall Street executive-turned-pharmaceutical-CEO, Martin Shkreli, quickly went viral after it was first featured in the New York Times on Sept. 20.

The same day, Clinton accused Shkreli of “price gouging” on Twitter, and teased her own plan to limit prescription drug prices that she would release the next day. The company also faced a barrage of headlines nationwide that focused in on the price increase and Shrekli, who become a public face of what critics call the drug industry's greed.

Shkreli, who also made headlines for inflammatory remarks about his unrelenting drive for profits, rolled back the drug increase on Sept. 21 – a move that the campaign is crediting to Clinton's pressure.

“A day after Clinton criticized the hike as "price gouging," the company's CEO reversed himself and pledged to cut the price of the drug,” her campaign wrote in a statement.

Clinton also went after Shkreli in a Facebook chat with supporters on Monday, urging the CEO to unveil the new cost of the drug.

“So Mr. Shkreli, what’s it going to be? Do the right thing. Lower the cost today to its original price,” she wrote.